Apotex Health Corp (APTX.TO) — Quality & forensics
As of 2026-10-27 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 48
- Quality 58
- Growth 36
- Balance sheet 37
- Cash quality 66
- Capital allocation 47
- Momentum 40
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the grey zone (1.81–2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the APTX.TO chart & overview
FAQ · from the current data · as of 2026-10-27
Quick answers
What is Apotex Health Corp's Closelooknet quality reading?
The composite reads 47/100 across 7 modules, as of 2026-10-27: valuation 48, quality 58, growth 36, balance sheet 37, cash quality 66, capital allocation 47, momentum 40. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Apotex Health Corp's Altman Z-Score?
2.09, which sits in the grey zone (1.81–2.99) as of 2026-10-27. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Apotex Health Corp's Piotroski F-Score?
7 of 9, as of 2026-10-27. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Apotex Health Corp's Beneish M-Score indicate?
-3.00 — below the −1.78 manipulation-risk threshold, as of 2026-10-27. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- ROVI.MC Laboratorios Farmaceuticos ROVIindustry
- LNTH Lantheus Holdings Incindustry
- BHC.TO Bausch Health Companies Incindustry
- KNSA Kiniksa Pharmaceuticals Ltdindustry
- AMRX Amneal Pharmaceuticals, Inc. Class A Common Stockindustry
- IRWD Ironwood Pharmaceuticals Incindustry
- PCRX Pacira BioSciences, Inc.industry
- HLUN-B.CO H Lundbeck A/Sindustry
- XERS Xeris Pharmaceuticals Incindustry
- UTHR United Therapeutics Corporationindustry
- GALDY GALDERMA GROUP AGindustry
- PRGO Perrigo Company PLCindustry
- GUD.TO Knight Therapeutics Inc.industry
- VTRS Viatris Incindustry
- VETO.PA Vetoquinolindustry
- 000538.SHE Yunnan Baiyao Group Co Ltdindustry
- FAGR.BR Fagron NVindustry
- AMPH Amphastar Pindustry
- CRON Cronos Group Incindustry
- FAE.MC Faes Farma SAindustry